Marrone Bio Innovations (MBII) Given a $4.00 Price Target by HC Wainwright Analysts

Marrone Bio Innovations (NASDAQ:MBII) received a $4.00 price objective from equities research analysts at HC Wainwright in a report issued on Thursday. The brokerage presently has a “buy” rating on the basic materials company’s stock. HC Wainwright’s price target suggests a potential upside of 270.37% from the stock’s previous close.

Separately, ValuEngine lowered Marrone Bio Innovations from a “sell” rating to a “strong sell” rating in a research report on Friday, September 1st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $2.50.

Marrone Bio Innovations (MBII) opened at $1.08 on Thursday. The company has a quick ratio of 0.36, a current ratio of 0.69 and a debt-to-equity ratio of -1.14. Marrone Bio Innovations has a 12-month low of $0.85 and a 12-month high of $2.45.

An institutional investor recently raised its position in Marrone Bio Innovations stock. Ardsley Advisory Partners lifted its holdings in Marrone Bio Innovations Inc (NASDAQ:MBII) by 375.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,681,580 shares of the basic materials company’s stock after acquiring an additional 2,907,142 shares during the period. Ardsley Advisory Partners owned approximately 11.74% of Marrone Bio Innovations worth $4,528,000 as of its most recent filing with the Securities and Exchange Commission. 37.59% of the stock is currently owned by institutional investors.

WARNING: This report was originally reported by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at https://www.com-unik.info/2017/12/23/marrone-bio-innovations-mbii-given-a-4-00-price-target-by-hc-wainwright-analysts.html.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit